| scholarly article | Q13442814 |
| P356 | DOI | 10.1097/00000658-200201000-00017 |
| P698 | PubMed publication ID | 11753052 |
| P2093 | author name string | Masaaki Inoue | |
| Tsunehiro Oyama | |||
| Kosei Yasumoto | |||
| Takeshi Oka | |||
| Toshihiro Osaki | |||
| Mantaro Kodate | |||
| Chun-Dong Gu | |||
| Kazuhito Dobashi | |||
| P2860 | cites work | Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. analysis and examples | Q24569561 |
| Revisions in the International System for Staging Lung Cancer | Q28241070 | ||
| The catalog of human cytokeratins: patterns of expression in normal epithelia, tumors and cultured cells | Q28262541 | ||
| C-erbB-2 expression and codon 12 K-ras mutations both predict shortened survival for patients with pulmonary adenocarcinomas. | Q34124421 | ||
| Keratin gene expression in non-epithelial tissues. Detection with polymerase chain reaction. | Q35832733 | ||
| Immunohistochemical study of p53 in human lung carcinomas. | Q35832962 | ||
| Survival in early-stage non-small cell lung cancer | Q40465859 | ||
| Molecular and pathologic markers in stage I non-small-cell carcinoma of the lung | Q40518313 | ||
| Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis | Q40694250 | ||
| Multifactorial analysis of p53 alteration in human cancer: a review | Q40736226 | ||
| Clinical implications of the p53 tumor-suppressor gene | Q40865658 | ||
| A randomized trial comparing preoperative chemotherapy plus surgery with surgery alone in patients with non-small-cell lung cancer. | Q42283680 | ||
| Relationship between early recurrence and micrometastases in the lymph nodes of patients with stage I non-small-cell lung cancer | Q43567801 | ||
| A randomized trial comparing perioperative chemotherapy and surgery with surgery alone in resectable stage IIIA non-small-cell lung cancer. | Q52377234 | ||
| Micrometastatic tumor cells in the bone marrow of patients with non-small cell lung cancer | Q58454740 | ||
| Mutations of the p53 Gene as a Predictor of Poor Prognosis in Patients With Non-Small-Cell Lung Cancer | Q58454765 | ||
| Aberrations of the p53 tumor suppressor gene in human non-small cell carcinomas of the lung | Q67857820 | ||
| ras gene mutations as a prognostic marker in adenocarcinoma of the human lung without lymph node metastasis | Q68119388 | ||
| Detection of disseminated lung cancer cells in lymph nodes: impact on staging and prognosis | Q70900070 | ||
| p53 nuclear immunostaining and gene mutations in non-small-cell lung cancer and their effects on patient survival | Q71045346 | ||
| Prognostic significance of abnormal p53 accumulation in primary, resected non-small-cell lung cancers | Q71093043 | ||
| Mode of spread in the early phase of lymphatic metastasis in non-small-cell lung cancer: significance of nodal micrometastasis | Q71518207 | ||
| Reverse transcriptase/polymerase chain reaction detection of cytokeratin-19 mRNA in bone marrow and blood of breast cancer patients | Q71740237 | ||
| Frequency and Distribution of Occult Micrometastases in Lymph Nodes of Patients With Non-Small-Cell Lung Carcinoma | Q72072302 | ||
| Proliferating cell nuclear antigen expression and argyrophilic nucleolar organizer regions as factors influencing prognosis of surgically treated lung cancer patients | Q72233627 | ||
| Incidence of local recurrence and second primary tumors in resected stage I lung cancer | Q72395348 | ||
| Micrometastatic P53-positive cells in the lymph nodes of non-small-cell lung cancer: prognostic significance | Q73716363 | ||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | lung cancer | Q47912 |
| P304 | page(s) | 133-139 | |
| P577 | publication date | 2002-01-01 | |
| P1433 | published in | Annals of Surgery | Q4767866 |
| P1476 | title | Detection of micrometastatic tumor cells in pN0 lymph nodes of patients with completely resected nonsmall cell lung cancer: impact on recurrence and Survival | |
| P478 | volume | 235 |
| Q35087715 | A novel immunohistochemical staining method allows ultrarapid detection of lymph node micrometastases while conserving antibody |
| Q58416209 | Blood vessel invasion in resected non small cell lung carcinomas is predictive of metastatic occurrence |
| Q35072531 | Clinical implications of immunohistochemically demonstrated lymph node micrometastasis in resectable pancreatic cancer |
| Q83879852 | Clinical significance of lymph node micrometastasis in ampullary carcinoma |
| Q38295006 | Current innovations in sentinel lymph node mapping for the staging and treatment of resectable lung cancer |
| Q40392739 | Detection of disseminated lung cancer cells in regional lymph nodes by assay of CK19 reverse transcriptase polymerase chain reaction and its clinical significance |
| Q37018090 | Detection of disseminated tumor cells in lymph nodes from patients with early stage non-small cell lung cancer |
| Q39434623 | Detection of occult tumor cells in regional lymph nodes is associated with poor survival in pN0 non-small cell lung cancer: a meta-analysis |
| Q37295669 | Evidence-based prevention (EBP): A review of cytochrome P450 expression in the bronchial epithelium and new approach to lung cancer prevention |
| Q45978106 | Gene diagnosis of micrometastases in regional lymph nodes of patients with stage I non-small cell lung cancer: impact on staging and prognosis. |
| Q36891235 | High expression of Y-box-binding protein 1 correlates with poor prognosis and early recurrence in patients with small invasive lung adenocarcinoma |
| Q79548136 | Impact of lymph node micrometastasis in patients with pancreatic head cancer |
| Q87366039 | Lack of supportive evidence for the use of immunohistochemical staining to identify occult regional lymph node metastases in primary lung cancer |
| Q24645961 | Low expression of polypeptide GalNAc N-acetylgalactosaminyl transferase-3 in lung adenocarcinoma: impact on poor prognosis and early recurrence |
| Q50504255 | Low perioperative serum prealbumin predicts early recurrence after curative pulmonary resection for non-small-cell lung cancer. |
| Q36645960 | Lung cancer lymph node micrometastasis detection using real-time polymerase chain reaction: correlation with vascular endothelial growth factor expression |
| Q35018681 | Lung cancer screening with CT |
| Q35925445 | Lymph node micrometastases are associated with disease recurrence and poor survival for early-stage non-small cell lung cancer patients: a meta-analysis |
| Q78424465 | Mitotic index does not predict prognosis in stage IA non-small cell lung cancer |
| Q54274131 | Molecular diagnosis and prognostic significance of lymph node micrometastasis in patients with histologically node-negative non-small cell lung cancer. |
| Q81312375 | Morphological and immunohistochemical characterization of isolated tumor cells by p53 status in gastrointestinal tumors |
| Q34746658 | Myeloid clusters are associated with a pro-metastatic environment and poor prognosis in smoking-related early stage non-small cell lung cancer |
| Q36085736 | Prognostic Value of Pleural Lavage Cytology in Patients with Lung Cancer Resection: An Updated Meta-Analysis |
| Q73615488 | Prognostic value of cytokeratin-positive cells in the bone marrow and lymph nodes of patients with resected nonsmall cell lung cancer: a multicenter prospective study |
| Q44566523 | Sentinel lymph node mapping and molecular staging in nonsmall cell lung carcinoma |
| Q38446050 | Significance of isolated tumor cells in lymph nodes among gastric cancer patients |
| Q40567420 | The prognostic significance of intranodal isolated tumor cells and micrometastases in patients with non-small cell carcinoma of the lung |
| Q48356862 | Using a novel NQO1 bioactivatable drug, beta-lapachone (ARQ761), to enhance chemotherapeutic effects by metabolic modulation in pancreatic cancer |
| Q53223722 | [Effects of thoracic paravertebral block on postoperative analgesia and serum level of tumor marker in lung cancer patients undergoing video-assisted thoracoscopic surgery]. |
| Q55464639 | [Long-term survival of personalized surgical treatment of locally advanced non-small cell lung cancer based on molecular staging]. |
| Q80352869 | [Micro-metastases and non-small cell lung cancer] |
| Q55433758 | [Research progress of lobe-specific lymphadenectomy on early stage lung cancer operation]. |
| Q83749676 | cT1aN0M0 lung adenocarcinoma treated with left S9+10 segmentectomy followed by completion lobectomy for a solitary metastasis (isolated tumor cells) in the neighboring segmental lymph node |
Search more.